Market Research Logo

Global Retinal Vein Occlusion Treatment Market 2019-2023

Global Retinal Vein Occlusion Treatment Market 2019-2023

About Retinal Vein Occlusion

Retinal vein occlusion (RVO) is the buildup of blood or other fluids in the retina of the eye, which prevents it from properly filtering the light caused by the blood clot.

Technavio’s analysts forecast the Global Retinal Vein Occlusion Market to grow at a CAGR of 9.40% during the period 2019-2023.

Covered in this report

The report covers the present scenario and the growth prospects of the retinal vein occlusion treatment market. To calculate the market size, the report considers the revenue generated by the sale of drugs for the treatment of retinal vein occlusion across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, retinal vein occlusion treatment market 2019-2023, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Allergan
  • Bayer
  • F. Hoffmann-La Roche
  • Novartis
  • Regeneron Pharmaceuticals
Market driver
  • Strong pipeline and recent drug approvals
  • For a full, detailed list, view our report
Market challenge
  • Side effects of RVO therapeutics
  • For a full, detailed list, view our report
Market trend
  • Advanced drug delivery techniques
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2023 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


  • Executive summary
  • Scope of the report
  • Market landscape
    • Market ecosystem
      • Table Global retinal disorders therapeutics market
      • Table Segments of global retinal disorders therapeutics market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by type
    • Table Type - Market share 2018-2023 (%)
    • Comparison by type
      • Table Comparison by type
    • BRVO - Market size and forecast 2018-2023
      • Table BRVO - Market size and forecast 2018-2023 ($ millions)
      • Table BRVO - Year-over-year growth 2019-2023 (%)
    • CRVO - Market size and forecast 2018-2023
      • Table CRVO - Market size and forecast 2018-2023 ($ millions)
      • Table CRVO - Year-over-year growth 2019-2023 (%)
    • Market opportunity by type
      • Table Market opportunity by type
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • Americas - Market size and forecast 2018-2023
      • Table Americas - Market size and forecast 2018-2023 ($ millions)
      • Table Americas - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Americas
    • EMEA - Market size and forecast 2018-2023
      • Table EMEA - Market size and forecast 2018-2023 ($ millions)
      • Table Increasing geriatric population in Europe (As per the World Bank)
      • Table EMEA - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in EMEA
    • APAC - Market size and forecast 2018-2023
      • Table APAC - Market size and forecast 2018-2023 ($ millions)
      • Table Increasing geriatric population in APAC
      • Table APAC - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Impact of drivers and challenges
  • Market trends
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • ALLERGAN
      • Table ALLERGAN - Vendor overview
      • Table ALLERGAN - Business segments
      • Table ALLERGAN - Organizational developments
      • Table ALLERGAN - Segment focus
      • Table ALLERGAN - Geographic focus
      • Table ALLERGAN - Segment focus
    • Bayer
      • Table Bayer - Vendor overview
      • Table Bayer - Business segments
      • Table Bayer - Organizational developments
      • Table Bayer - Segment focus
      • Table Bayer - Geographic focus
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche - Overview
      • Table F. Hoffmann-La Roche - Business segments
      • Table F. Hoffmann-La Roche - Organizational developments
      • Table F. Hoffmann-La Roche - Geographic focus
      • Table F. Hoffmann-La Roche - Segment focus
    • Novartis
      • Table Novartis - Vendor overview
      • Table Novartis - Business segments
      • Table Novartis - Organizational developments
      • Table Novartis - Geographic focus
      • Table Novartis - Segment focus
    • Regeneron Pharmaceuticals
      • Table Regeneron Pharmaceuticals - Vendor overview
      • Table Regeneron Pharmaceuticals - Business segments
      • Table Regeneron Pharmaceuticals - Organizational developments
      • Table Regeneron Pharmaceuticals - Segment focus
      • Table Regeneron Pharmaceuticals - Key customers
  • Appendix
    • Research methodology
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report